RecruitingNot ApplicableNCT04705038
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments
A Feasibility Study of Orchiectomy in Patients With Prostate Cancer on Chronic LHRH Agonist or Antagonist Therapy
Sponsor
University of Chicago
Enrollment
100 participants
Start Date
Dec 18, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Diagnosis of metastatic prostatic adenocarcinoma
- Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy
- Able to complete written surveys in English
Exclusion Criteria1
- More than 2 prior systemic treatment regimens utilized in addition to castration.
Interventions
BEHAVIORALPatient Education
Brief educational session on surgical castration as an alternative to lifelong ADT for prostate cancer.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04705038
Related Trials
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
NCT057519412 locations